Active Ingredient History
Ziprasidone is atypical antipsychotic, approved by the U.S. Food and Drug Administration for the treatment of schizophrenia, and acute mania and mixed states associated with bipolar disorder. Intramuscilar injections of Ziprasidone are indicated for rapid control of the agitation in schizophrenic patients. Ziprasidone is used off-label for treatment of major depressive disorder, anxiety, obsessive compulsive disorder, borderline personality disorder. Ziprasidone functions as an antagonist at the D2, 5HT2A, and 5HT1D receptors, and as an agonist at the 5HT1A receptor. NCATS
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Schizophrenia (approved 2001)
Affective Disorders, Psychotic (Phase 4)
Analgesics, Opioid (Early Phase 1)
Antipsychotic Agents (Phase 4)
Anxiety (Phase 4)
Anxiety Disorders (Phase 4)
Autistic Disorder (Phase 2)
Behavior, Addictive (Early Phase 1)
Bipolar Disorder (Phase 4)
Borderline Personality Disorder (Phase 2)
Cardiovascular Diseases (Phase 1)
Cognition Disorders (Phase 3)
Conduct Disorder (Phase 2)
Delirium (Phase 4)
Dementia (Phase 3)
Depression (Phase 4)
Depressive Disorder, Major (Phase 3)
Diabetes Mellitus (Phase 4)
Diabetes Mellitus, Type 2 (Phase 4)
Healthy Volunteers (Phase 4)
Hyperglycemia (Phase 4)
Insulin Resistance (Phase 4)
Mania (Phase 4)
Medication Adherence (Phase 4)
Mental Health (Phase 4)
Metabolic Syndrome (Phase 4)
Mood Disorders (Phase 4)
Opioid-Related Disorders (Early Phase 1)
Panic Disorder (Phase 4)
Phobia, Social (Phase 2)
Psychology, Clinical (Phase 3)
Psychophysiologic Disorders (Phase 3)
Risk Factors (Phase 4)
Schizophrenia (Phase 4)
Schizophrenia, Paranoid (Phase 4)
Stress Disorders, Post-Traumatic (Phase 4)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue